Tag: checkpoint therapeutics
March 13, 2019
Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101
Checkpoint Therapeutics (NASDAQ:CKPT) has announced that the European Patent Office (EPO) has issued a composition of matter patent for the...
January 13, 2019
5 Top Weekly NASDAQ Biotech Stocks: Index Up During JPM Week
Axsome Therapeutics, Checkpoint Therapeutics, Bellerophon Therapeutics, Enochian Bioscience and Equillium were last week's top gainers. November 2, 2018
Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results
Checkpoint Therapeutics (NASDAQ:CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients... September 6, 2018